Progenitor cells regenerate heart muscle and repel scar-forming fibroblasts
Our latest research published in Nature Cell Biology reveals the mechanisms that enable human progenitor cells to migrate to the site of cardiac injury and regenerate heart cells, while simultaneously repelling fibroblasts to prevent fibrotic scarring. 0:55. Background 2:50. HVP form functional ventricular cardiomyocytes 3:06. Ex vivo co-culture with native NHP-LV 5:05. HVPs migrate and remuscularise acutely damaged myocardium 6:36. HVPs are chemoattracted to sites of cardiac injury 9:26. HVPs remuscularise chronic scars of chronic ischaemia in vivo. 13:08. Conclusion ------------------------------------------------------------ Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: Twitter: / astrazeneca LinkedIn: / astrazeneca Instagram: / astrazeneca Facebook: / astrazeneca

New muscle for failing hearts

The potential of T-cell receptor therapies

Mene Pangalos awarded knighthood in recognition of his services to UK science

The Discovery Centre (DISC): Unlocking the power of science

Living with Cardiomyopathy: Richard’s story

Early Talent at AstraZeneca: Shaping the Future Together

Living With Obesity: Nicci’s Journey

Combining CRISPR and AI to accelerate cancer drug discovery

In Vivo Cell Therapy

Lab4Life: A day in the life of a scientist

The AstraZeneca story

CVRM Clinical Trials of the Future

Chronic kidney disease: a patient story

Realising the Full Curative Potential of Cell Therapy

Full-Year 2025 Results

Title: Global Operations at AstraZeneca – Change a Life

AstraZeneca IT – Follow the Sun

Cell therapy uncovered: advancing cell therapy in the clinic

Living with Blood Cancer: Tania’s Story

